A phase 1b study of zelpultide alfa demonstrated a favorable safety profile and encouraging early reductions in BPD and ventilation duration, supporting advancement to a pivotal international Phase 2b/3 program.
Daniele De Luca, MD, PhD
Advertisement
Daniele De luca : Professor of Neonatology at Paris Saclay University and division chief of the NICU at the Beclere hospital in Paris, Past President and honorary lifetime member of ESPNIC.
Articles by Daniele De Luca, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Redefining type 1 diabetes: Early identification, staging, and clinical implications for pediatric care
2
CDC updates website, opens door for autism and vaccines link
3
Practical reminders, considerations for anaphylaxis care, with Alice Hoyt, MD, FAAAI
4
FDA approves EYLEA HD injection 8 mg to treat macular edema following RVO and monthly dosing
5
